Form 4 for MDCX Medicus Pharma Ltd.
Accepted 2025-08-14 00:00:00 ET · period of report 2025-08-13 · accession 0000950142-25-002189 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-08-14 | 2025-08-13 | MDCX | Quinlan James P. | CFO | M - OptEx | $1.08 | +145.0K | 274.1K | +112% | +$156.2K |
| DM | 2025-08-14 | 2025-08-13 | MDCX | Quinlan James P. | CFO | M - OptEx | $0.00 | -145.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, no par value ("Common Shares") | 2025-08-13 | M | A | 125,000 | $0.81 | 254,147 | D | — | — | (F1) Represents an exercise price of $1.16 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024. |
| 2 | Common | Common Shares | 2025-08-13 | M | A | 20,000 | $2.75 | 274,147 | D | — | — | (F2) Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024. |
| 3 | Derivative | Stock Option (right to buy) | 2025-08-13 | M | D | 125,000 | $0.00 | 0 | D | $0.81 · — to 2028-10-24 | 125,000 Common Shares | (F1) Represents an exercise price of $1.16 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024. (F3) The option was vested and was exercisable as of the Transaction Date. |
| 4 | Derivative | Stock Option (right to buy) | 2025-08-13 | M | D | 20,000 | $0.00 | 0 | D | $2.75 · — to 2029-12-17 | 20,000 Common Shares | (F2) Represents an exercise price of $3.95 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024. (F3) The option was vested and was exercisable as of the Transaction Date. |